MetaCap

Rani Therapeutics Insider Trades

NASDAQ: RANIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.5111-0.0695 (-11.97%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
2 · $50.03K
Sales
1 · $301.08
Shares bought / sold
71.00K / 386
Net activity
Net buying $49,732

Rani Therapeutics insider activity

Over the last 12 months, Rani Therapeutics insiders reported 10 transactions on SEC Form 4: 2 open-market purchases and 1 sale. Insiders bought $50,033 and sold $301 worth of stock, for net insider buying of $49,732. The largest seller was Javadi Alireza, with $301 in reported sales.

The most recent filing shows Imran Talat (Chief Executive Officer) reporting a transaction in 7,928 shares at $0.7592 on Sep 27, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RANI's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

RANI insider transactions

Rani Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Sep 27, 2026Javadi AlirezaChief Technical OfficerTax withholding309$234.59Form 4
Sep 27, 2026Imran TalatChief Executive OfficerTax withholding7,928$6.02KForm 4
Jul 21, 2026IMRAN MIR ADirectorBuy36,000$24.84KForm 4
Jul 17, 2026Imran TalatChief Executive OfficerBuy35,000$25.19KForm 4
Jun 27, 2026Javadi AlirezaChief Technical OfficerTax withholding309$228.66Form 4
Jun 27, 2026Imran TalatChief Executive OfficerTax withholding7,927$5.87KForm 4
Mar 27, 2026Javadi AlirezaChief Technical OfficerSale386$301.08Form 4
Mar 27, 2026Imran TalatChief Executive OfficerTax withholding9,099$7.37KForm 4
Mar 22, 2026Imran TalatChief Executive OfficerTax withholding8,916$10.08KForm 4
Dec 27, 2025Imran TalatChief Executive OfficerTax withholding7,906$11.07KForm 4
Oct 23, 2025IMRAN MIR ADirectorBuy2,083,334$1.26MForm 4
Oct 21, 2025South Cone Investments Limited Partnership10% OwnerSale4,000,000$11.07MForm 4
Oct 20, 2025South Cone Investments Limited Partnership10% OwnerSale1,923,000$4.64MForm 4
Sep 27, 2025Imran TalatChief Executive OfficerTax withholding9,077$4.36KForm 4
Jun 27, 2025Imran TalatChief Executive OfficerTax withholding9,076$4.99KForm 4
Dec 27, 2024Imran TalatChief Executive OfficerSale8,014$11.30KForm 4
Dec 13, 2024McKinley KateChief Business OfficerBuy17,960$29.99KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related